Levemir FlexPen 100 U/mL is a long-acting Insulin Detemir formulation developed by Novo Nordisk to deliver stable and predictable basal insulin coverage. Designed for precision and convenience, this prefilled pen ensures consistent glucose control and smooth day-to-day diabetes management.
Key Benefits
✔ Provides up to 24-hour basal insulin coverage with stable absorption.
✔ Ensures predictable glucose-lowering effect with low variability.
✔ Reduces risk of nocturnal hypoglycemia compared to intermediate-acting insulins.
✔ Offers flexible dosing options for individualized treatment plans.
✔ Convenient prefilled FlexPen for accurate, easy, and hygienic self-administration.
✔ Manufactured by Novo Nordisk, a global leader in insulin innovation and quality.
Product Specifications:
Product: Levemir® FlexPen
Molecule: Insulin Detemir
Potency: 100 U/mL
Appearance: Clear, colorless injectable solution in prefilled pen
Dosage: Administer once or twice daily as directed by a healthcare professional
Packing: Box of 5 prefilled pens
How It Works
Levemir (Insulin Detemir) mimics the natural basal insulin secretion of the pancreas, maintaining stable glucose levels between meals and overnight. Its molecular modification enables a prolonged and consistent release, ensuring sustained glucose control and reducing fluctuations commonly seen with shorter-acting insulins.
Who Is It For?
✅ Adults and children with Type 1 or Type 2 diabetes requiring basal insulin support
✅ Healthcare professionals managing patients with long-term insulin needs
✅ Patients seeking flexible dosing and smoother glucose stability
✅ Endocrinologists and diabetologists optimizing long-term glycemic outcomes
keywords: insulin คือ, insulin syringes, nph ยา, ยา insulin, insulin ยา, novorapid penfill, insulin pen, novorapid flexpen, novorapid insulin, NovoRapid ราคา, Cost of insulin in Thailand
Levemir FlexPen 100 U/mL – Long-Acting Insulin Detemir
Both Lantus (Insulin Glargine) and Levemir (Insulin Detemir) are long-acting basal insulins that help control blood sugar between meals and overnight.
However, Levemir may require twice-daily dosing in some patients, while Lantus is usually once daily. Their duration and absorption profiles differ slightly, but both achieve similar glucose-lowering effects.
